Comparing 11 vendors in Single Use Bioprocessing across 0 criteria.
ContendersMarket Leaders 
Emerging CompaniesInnovators 
Merck
Entegris
Sartorius
Eppendorf
Parker Hannifin
Corning
Getinge
Avantor
Thermo Fisher Scientific
Danaher
Repligen
Access Research To
- Expand Total Addressable Market
- Formulate Go To Market Plans
- Build Competitive Right to Win
- Identify Top Customers to Grow
Error!!!
Oops! Something went wrong. Please try again later.
POWERED BY MARKETSANDMARKETS
Sep 21, 2023
360 Quadrants releases a list of "Top 11 Single Use Bioprocessing Companies, Worldwide 2023" in partnership with MarketsandMarkets. The report recognizes standouts in Single Use Bioprocessing, ranging from mid-sized enterprises to Fortune 500 companies. The vendor evaluation was conducted on over two hundred companies of which the top 11 were categorized and recognized as the new economic quadrant leaders.
Key trends highlighted in 360 Quadrants:
- The global single-use bioprocessing market is projected to reach USD 20.76 billion by 2026 from USD 8.18 billion in 2022, at a CAGR of 20.5% during the forecast period. Factors such as the increasing demand for biopharmaceuticals & energy efficiency, the need to reduce water wastage, equipment floor space requirement, and the risk of cross-contamination are the key factors driving the growth of the single-use bioprocessing market. However, extractability and leachability issues regarding disposable components and environmental & economic concerns are the major factors restraining market growth.
- North America accounted for this market’s largest share, followed by Europe in 2022. Increasing demand for biopharmaceuticals, especially from the aging population, growth in R&D investments by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the single use bioprocessing market in North America. The Asia Pacific region is expected to grow owing to factors such as expanding the biomanufacturing sector, increasing government support, developing R&D infrastructure, and growing outsourcing in this region from North America and Europe.
- Based on the product, the single-use bioprocessing market is categorized into single-use media bags, and containers, single-use assemblies, single-use bioreactors, disposable mixers, and other products. In 2022, the single-use media bags and containers segment accounted for the largest share of the market. It was majorly due to the benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharmaceutical applications.
- The key players in the market include Thermo Fisher Scientific (USA), Sartorius (France), Merck (Germany), and Danaher (USA). Product launches, expansions, acquisitions, and collaborations are the various strategies adopted by these companies in order to strengthen their position in the market. For instance, in April 2023, Sartorius and va-Q-tec (Germany) announced a long-term partnership for the joint development of innovative transport systems for the biopharmaceutical industry. Another company, Merck during the same period launched its Ultimus Single-Use Process Container Film, designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.
The Full List
The Full List
| Company | Headquarters | Year Founded | Holding Type |
|---|---|---|---|
| Avantor | Radnor Township, USA | 1904 | Public |
| Corning | Corning, USA | 1851 | Public |
| Danaher | Washington, D.C., USA | 1984 | Public |
| Entegris | Billerica, USA | 1966 | Public |
| Eppendorf | Hamburg, Germany | 1945 | Private |
| Getinge | Getinge, Sweden | 1904 | Public |
| Merck | Darmstadt, Germany | 1668 | Public |
| Parker Hannifin | Cleveland, USA | 1917 | Public |
| Repligen | Waltham,USA | 1981 | Public |
| Sartorius | Göttingen, Germany | 1870 | Public |
| Thermo Fisher Scientific | Waltham, USA | 1956 | Private |
Frequently Asked Questions (FAQs)
Single-use bioprocessing refers to the use of disposable, pre-sterilized components and equipment in biopharmaceutical manufacturing processes. It eliminates the need for cleaning, sterilization, and validation of traditional stainless-steel equipment, offering increased flexibility, reduced costs, and faster turnaround times.
Single-use bioprocessing offers several advantages over traditional stainless steel systems. Firstly, it eliminates the need for cleaning and sterilization, saving time and reducing the risk of cross-contamination. It also minimizes the risk of product carryover between batches, ensuring product integrity. Single-use systems are flexible and easily scalable, allowing for efficient and cost-effective production. They require smaller facility footprints, reducing capital costs and environmental impact. Additionally, single-use bioprocessing enables rapid process turnaround and facilitates process optimization. It enhances operational efficiency by eliminating equipment maintenance and validation. Overall, single-use bioprocessing offers improved productivity, reduced costs, and enhanced operational flexibility in biopharmaceutical manufacturing.
Single-use bioprocessing systems consist of several key components that enable the processing of biopharmaceuticals. These components include:
Bags and Containers: Single-use bioprocessing commonly utilizes flexible bags and containers made of biocompatible materials such as polyethylene, polypropylene, or fluoropolymers. These bags serve as the primary vessels for holding and transporting process fluids, including media, buffers, and cell culture.
Tubing and Connectors: Bioprocessing systems employ a variety of tubing made from materials like silicone, thermoplastic elastomers, or polyethylene. Tubing is used to transfer fluids between different components, such as bags, filters, pumps, and bioreactors. Connectors ensure a secure and sterile connection between various tubing segments.
Filters: Filters are critical for removing impurities and particulates from process streams. They help maintain the integrity and quality of the product. Filters can be incorporated at different stages of the process, such as pre-filtration, depth filtration, and sterile filtration.
Bioreactors: Single-use bioreactors are disposable vessels designed for cell cultivation and fermentation. They come in various configurations, including stirred-tank, wave-mixed, or air-lift bioreactors. Bioreactors often feature integrated sensors for monitoring and controlling parameters like pH, dissolved oxygen, and temperature.
Sensors and Control Systems: Single-use bioprocessing systems may incorporate sensors to monitor process parameters and ensure optimal conditions. These sensors measure variables such as pH, temperature, dissolved oxygen, and pressure. Control systems interpret sensor data and enable automated adjustments for maintaining process parameters within desired ranges.
Harvest and Separation Devices: Devices such as centrifuges, depth filters, and chromatography columns are employed for cell harvesting, cell clarification, and downstream purification steps. These devices enable the separation and recovery of target biomolecules.
Sampling and Monitoring Equipment: Single-use bioprocessing systems incorporate sampling ports and equipment for process monitoring and quality control. This includes tools for taking samples for analytical testing and monitoring critical process parameters during production.
These components work together to create a complete and efficient single-use bioprocessing system, providing a flexible and disposable approach to biopharmaceutical manufacturing.
Single-use bioprocessing systems are designed to be sterile and pre-sterilized. They eliminate the need for cleaning and sterilization steps, reducing the risk of cross-contamination between batches. Additionally, single-use systems can be discarded after use, minimizing the potential for product carryover and reducing the need for extensive cleaning and validation procedures.
While single-use bioprocessing offers numerous advantages, it also presents some challenges. One key challenge is the risk of leachables and extractables from the disposable materials, which can potentially impact product quality and safety. Maintaining the integrity of the single-use components during handling and transport is another concern. Single-use systems can be more susceptible to physical damage or breaches compared to stainless steel systems. The scalability of single-use bioreactors to larger volumes is also a challenge. Furthermore, the disposal of large quantities of single-use plastic materials raises environmental concerns. These challenges require ongoing research, development, and regulatory guidance to ensure the safe and sustainable implementation of single-use bioprocessing.
Single-use bioprocessing systems can be scalable, but the scalability depends on the specific technology and process being employed. Some single-use bioreactors and filtration systems have limitations in terms of scale, which may require process modifications or the use of multiple smaller-scale units for large-scale production.
Single-use bioprocessing systems can offer cost advantages in certain scenarios. They eliminate the need for capital investment in stainless-steel equipment, reduce water and energy consumption, and simplify cleaning and validation procedures. However, the overall cost-effectiveness depends on the specific process, scale, and duration of production.
Single-use bioprocessing systems are suitable for a wide range of biopharmaceutical processes, including cell culture, fermentation, filtration, and purification. However, certain specialized processes or large-scale production may still rely on traditional stainless-steel equipment.
Single-use bioprocessing can impact process validation in several ways. Traditional stainless steel systems require extensive cleaning and sterilization validation to ensure product safety. With single-use systems, the need for cleaning and sterilization is eliminated, simplifying validation efforts. The validation focus shifts towards the performance of the disposable components, such as bag integrity and functionality. As single-use systems are pre-sterilized and pre-assembled, their validation can involve confirming the integrity of the system, verifying appropriate connection and sealing, and assessing the performance of critical process steps. Single-use bioprocessing enables faster turnaround times, reducing the time and effort required for process validation activities.
The adoption of single-use bioprocessing is expected to continue growing in the biopharmaceutical industry. Ongoing advancements in single-use technology, such as larger-scale disposable bioreactors and improved sensor integration, are addressing some of the limitations and challenges associated with single-use systems. The focus on cost reduction, flexibility, and operational efficiency will likely drive further innovation in this field.
Research Methodology
If your company is recognised in this Quadrant, Leverage this ranking using our Marketing Kit.
